Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Mediastinal Lymphoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Lymphoma by Site
Mediastinal Lymphoma

Hematologic Malignancy

Mediastinal Lymphoma

CI-CAN-00003276Explore in graph →

Hematologic63 active trials1 approved drugs

NCIt: C6633

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials141
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 36
Ph III recruiting: 1
Growth YoY: —
Industry share: 22%
Top sponsor: University of Washington
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

StatusAll Active (any)Recruiting 45 Completed 41 Active Not Recruiting 25 Unknown 8 Terminated 7 Not Yet Recruiting 5 Withdrawn 4 Enrolling By Invitation 3 Suspended 2 Approved For Marketing 1

PhaseAll Early Phase 1 2 N/A 9 Phase 1 64 Phase 2 64 Phase 3 2 Phase 4 1

No study matches these filters